Validation of gamma probe detection of the sentinel node in melanoma

Journal of Nuclear Medicine

Volumn 38, Issue 3, 1997, Pages 362-366

  Kapteijn, B A E ^a   Nieweg, O E ^a   Muller, S H ^a   Liem, I H ^a   Hoefnagel, C A ^a   Rutgers, E J Th ^a   Kroon, B B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Gamma probe; Lymphoscintigraphy; Melanoma; Sentinel node; Technetium 99m aggregated albumin

Indexed keywords

ADULT; ARTICLE; CANCER RISK; DIAGNOSTIC VALUE; FEMALE; HUMAN; ISOTOPE LABELING; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; FEMALE; GAMMA RAYS; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0030959802     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Balch CM, Soong SJ, Shaw HM, et al. Changing trends in the clinical and pathologic features of melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous melanoma, 2nd ed. Philadelphia, PA: J.B. Lippincott Co.; 1992:40-45.
2. McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery 1964;56:512-518.
3. Karakousis CP, Emrich LJ, Rao U. Groin dissection in malignant melanoma. Am J Surg 1986;152:491-495.
4. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983; 51:2152-2156.
5. Ames FC, Singletary SE. Cutaneous malignancies of the trunk and lower extremities. In: Johnson DE, Ames FC, eds. Groin dissection. Chicago, IL: Year Book Medical Publishers Inc.; 1985:111-136.
6. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 1986;73:906-908.
7. Baas PC, Schraffordt Koops H, Hoekstra HJ, van Bruggen JJ, van der Weele LT, Oldhoff J. Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg 1992;127:281-286.
8. Das Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Arch Surg 1977;186:201-209.
9. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-388.
10. Cohen MH, Ketcham AS, Felix EL, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977;297:627-630.
11. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in Stage I melanoma of the limbs. N Engl J Med 1977;297:627-630.
12. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in Stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-2430.
13. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of Stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
14. Balch CM. The role of elective lymph node dissection in melanoma: Rationale, results and controversies. J Clin Oncol 1988;6:163-172.
15. Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1786 patients with localized (Stage I) melanoma treated in Alabama and New South Wales, Australia. Ann Surg 1982;196:677-684.
16. Drepper H, Köhler CO, Bastian B, et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Cancer 1993;72:741-749.
17. Kroon BBR, Jonk A. Elective lymph node dissection in melanoma: still a controversial issue. Nether J Surg 1991;43-4:129-132.
18. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
19. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-767.
20. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993;34:1435-1440.
21. Kapteijn BAE, Baidjnath Panday RKL, Liem IH, et al. Lymphoscintigraphy and intraoperative gamma probe detection of the first draining lymph node in clinically localized melanoma. J Nucl Med 1995;36:222.
22. Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995;22:1238-1241.
23. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-658.
24. Godellas CV, Berman CG, Lyman G, et al. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surgeon 1995;61:97-101.
25. Essner R, Foshag L, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical Stage I melanoma. Soc Surg Oncol 1994:104.
26. Das Gupta T, McNeer G. The incidence of metastasis to accessible lymph nodes from melanoma of the trunk and extremities - its therapeutic significance. Cancer 1964:897-911.
27. West JH, Seymour JC, Drane WE. Combined transmission-emission imaging in lymphoscimigraphy. Clin Nucl Med 1993;18:762-764.
28. Kapteijn BAE, Nieweg OE, Valdés Olmos RA, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1997;37:972-975.
29. Mudun A, Murray DR, Herda SC, et al. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection and effectiveness of the intraoperarive gamma probe. Radiology 1996;199:171-175.
30. 99mTc-antimony sulfur colloid. Am J Radiology 1981;137:847-851.
31. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993;2:303-308.
32. Hotze A, Mahlstedt J, Wolf F. Radiopharmaceuticals for hone marrow imaging. In: Mahlstedt J, ed Bone marrow imaging. Darmstadt, Germany: GIT Verlag Ernst Giebeler; 1984:5-7.
33. 99mTc. Min Med 1986;77:313-316.
34. 99mTc-labeled microcolloids used for lymphoscintigraphy [Abstract]. Eur J Nucl Med 1984;9:A43.
35. Lamki LM, Haynie TP, Balch CM, et al. Lymphoscintigraphy in the surgical management of patients with truncal melanoma: comparison of technetium sulfur colloid with technetium human serum albumin [Abstract]. J Nucl Med 1489;30:844.